Latest news, press releases, and SEC filings for GSK plc (GLAXF) https://caymanjournal.com/stock/GLAXF en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Fri, 01 May 2026 09:49:32 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **Form 6-K** from GSK plc, a required monthly filing for foreign companies listed in the U.S. Its sole purpose is to announce one specific action: the company bought back some of its own shares on April 22, 2026. Think of it as a receipt and official notice for a https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003814 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003814 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing The data provided consists of sequential records, each representing a transaction or an event. Assuming this structure is representative of transactional data, it's best used for analysis, data loading, or reporting. Here is a structured overview of the data's presumed components: ### Data Structu https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003778 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003778 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing Here is a summary of the provided data, categorized by the key elements present: **Data Source:** Log/Activity log **Timeframe:** Multiple timestamps throughout the recording. **Key Entities:** * **Coordinates/Values:** Numeric measurements. * **Tags/Context:** Descriptive labels. ### Analysis by https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003750 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003750 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing The provided data is a log of time-stamped events, likely representing network or system activity. To make it more usable, I have organized it into a structured table format. Here is the structured data: | Timestamp | Event Details | | :--- | :--- | | 2024-04-29 13:00:00 | 2024-04-29 13:00:00 | | https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003688 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003688 Mon, 20 Apr 2026 00:00:00 GMT SEC Filing # 📰 What This Document Is 📰 This document is a Form 6-K, which is a report filed by a foreign private issuer (GSK plc) with the U.S. Securities and Exchange Commission. Think of it as an international progress report that lets U.S. investors know about important operational updates happening outs https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003693 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003693 Mon, 20 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K** from GSK plc, a standard monthly filing that foreign companies use to update the SEC. This specific filing announces a routine share buyback. Think of it as a public receipt for a stock shopping spree the company completed on a single day. # 🏢 What https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003393 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003393 Fri, 10 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K**, a routine report that foreign companies like GSK file with the U.S. Securities and Exchange Commission (SEC) to announce material events. This specific report announces that GSK bought back some of its own shares on the open market. Think of it as a https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003274 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003274 Tue, 07 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a Form 6-K, a report GSK files with the U.S. SEC as a foreign company. It's a formal announcement confirming the completion of a major ownership change within its key HIV business. Essentially, it’s the official "it's done" notice to investors. # 🏢 ViiV Healthcar https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003119 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-003119 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K**, a monthly report GSK files with the U.S. SEC as a foreign company. Think of it as a "news bulletin" update for investors. This specific filing contains one major announcement: the **regulatory approval of a new drug in China**. 👉 **Why it matters: https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-002916 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-002916 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K** from GSK, a monthly update required for foreign companies listed on U.S. stock exchanges. It's a **news release** announcing a major regulatory milestone for one of its key drugs. 👉 In simple terms: GSK is telling the world, "Our promising new hepa https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-002919 https://caymanjournal.com/stock/GLAXF/sec-filing/0001654954-26-002919 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing